• admin@sclerose.info
Dansk DA English EN Español ES

Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent lower mortality risk than those that did not take the drug. This was particularly evident among MS patients who took beta interferon for more than three years.


https://www.sciencedaily.com/releases/2019/03/190318132638.htm

More Posts

Accept af sclerose.

Accept af sclerose ?!?!?!?! Det er altid svært at tale om, og gøre, og føle.Har du accepteret at du har sclerose… ?Det er et emne